Clinical trial
Comparison of Two Approaches to Insulin Therapy in Patients With Type 2 Diabetes…
NCT00377858 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00377858 |
|---|---|
| Title | Comparison of Two Approaches to Insulin Therapy in Patients With Type 2 Diabetes (IOOX) |
| Official title | Comparison of Two Approaches to Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes and Inadequate Glycemic Control on Oral Therapy: Comparison of Premixed Insulin Lispro Mid Mixture With Separate Basal and Bolus Insulin Injections |
| Acronym | IOOX |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Insulin lispro mid mixture (MM), Insulin glargine |
| Enrollment | 484 |
| Start date | Aug 1, 2006 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Sep 19, 2006 |
| Last update posted | Dec 9, 2009 |
| Countries | Australia, Canada, France, Mexico, Russia, South Korea, Spain |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: